(DLB) |
| 0 (0%) 04-14 05:04 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 76.39 |
| Resistance 1: | 65.40 |
| Pivot price: | 60.13 |
| Support 1: | 60.59 |
| Support 2: | 57.62 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 2.470 |
| Book Value | 27.150 |
| PEG Ratio | 0.00 |
| Gross Profit | 19.382 |
| Profit Margin (%) | 17.97 |
| Operating Margin (%) | 20.95 |
| Return on Assets (ttm) | 5.3 |
| Return on Equity (ttm) | 9.5 |
Company news
Mon, 13 Apr 2026
CGTX: Phase III trials for zervimesine in DLB psychosis and Alzheimer's are advancing with strong safety and efficacy data - TradingView — Track All Markets
Mon, 13 Apr 2026
Cognition Therapeutics Targets Faster DLB Psychosis Path as Zervimesine Nears Late-Stage Plans - Yahoo Finance
Fri, 10 Apr 2026
TCND.CA Stock Price, Quote & Chart | BETAPRO 3X SPTSX60 DLB ALT (TSX:TCND) - ChartMill
Thu, 09 Apr 2026
Spotting Winners: Dolby Laboratories (NYSE:DLB) And Design Software Stocks In Q4 - FinancialContent
Thu, 09 Apr 2026
How (DLB) Movements Inform Risk Allocation Models - Stock Traders Daily
Thu, 09 Apr 2026
Oak Thistle LLC Purchases Shares of 25,184 Dolby Laboratories $DLB - MarketBeat
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
